- Home
- MDBH vs GNTA Comparison
MDBH vs GNTA Comparison
Compare MDBH & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDBH | GNTA |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.0M | 34.0M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MDBH | GNTA |
|---|---|---|
| Price | $3.43 | $1.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.6K | ★ 98.0K |
| Earning Date | 11-13-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | ★ $1,250,398.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.42 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.16 | $1.28 |
| 52 Week High | $7.98 | $10.00 |
Technical Indicators
Market Signals| Indicator | MDBH | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 50.50 | 36.36 |
| Support Level | $3.17 | $1.28 |
| Resistance Level | $3.62 | $1.68 |
| Average True Range (ATR) | 0.17 | 0.18 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 57.78 | 22.78 |
Price Performance
Historical ComparisonAbout MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.